FB1006

· Peking University Third Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FB1006, covering 2023-11-22 to 2023-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients [Phase 4]